目的:探讨基质细胞衍生因子-1α(stromal cell derived factor-1α,SDF-1α)在人脑胶质瘤中的表达及其与胶质瘤血管生成的相关性。方法:以58例人脑胶质瘤及18例正常脑组织为研究对象,应用免疫组织化学方法检测SDF-1α及CD105的表达情况,并计数CD105标记的微血管密度(microvessel density, MVD)。结果:正常脑组织中未见SDF-1α表达。SDF-1α标记指数及CD105-MVD与胶质瘤病理分级密切相关(P＜0.01),SDF-1α标记指数与CD105-MVD均呈正相关(r=0.872, P＜0.01)。SDF-1α表达和CD105-MVD与患者的年龄、性别及瘤体大小无明显相关性(P＞0.05)。结论:SDF-1α和CD105-MVD可作为反映胶质瘤恶性程度的指标;SDF-1α在胶质瘤中表达增加可能引起胶质瘤的发生、发展;SDF-1α可能通过促进血管内皮细胞向肿瘤迁移,从而刺激肿瘤血管的生成。

Objective To explore the expression of stromal cell derived factor-1α (SDF-1α) in human glioma and its relationship with glioma angiogenesis. Methods Altogether 58 cases of gliomas and 18 normal brain tissues were selected for our study. The expressions of SDF-1α and CD105 were detected by immunohistochemistry, and CD105 marked microvessel density (MVD) was counted. Results Expression of SDF-1α was not found in normal brain tissues. SDF-1α marked index and CD105-MVD were closely related to the grade of glioma (P＜0.01). SDF-1α marked index was positively correlated with CD105-MVD (r=0.872, P＜0.01). SDF-1α expression and CD105-MVD were negatively correlated with patients' age, gender, and the tumor size (P＞0.05). Conclusion SDF-1α and CD105-MVD could serve as indexes for malignant degree of glioma. Increased expression of SDF-1α in glioma may lead to the pathogenesis and development glioma. SDF-1α may induce the tumor vessel formation by promoting the migration of vascular endothelial cells to tumor.

[1] Mellinghoff IK, Lassman AB, Wen PY. Signal transduction inhibitors and antiangiogenic therapies for malignant glioma［J］. Glia, 2011,59(8):1205-1212.

[2] Balkwill F. Chemokine biology in cancer［J］. Semin Immunol, 2003, 15(1): 49-55.

[3] Wikstrom P, Lissbrant IF, Stattin P, et al.Endoglin(CD105) is expressed on immature blood vesels and is a marker for survival in prostate cancer［J］.Prostate, 2002, 51(4): 268-275.

[4] Kleihues P, Cavenee WK. WHO classification of tumors, pathology and genetics of tumor of tumors of the nervous system［M］. Lyon: IARC Press, 2000: 1-253.

[5] Weidner N. Chapter 14. Measuring intratumoral microvessel density［J］. Methods Enzymol,2008,444:305-323.

[6] 陈琼,武明花,周艳宏,等.LRRC4通过SDF-1α/CXCR4生物学轴抑制脑胶质瘤细胞侵袭迁移能力［J］.中南大学学报:医学版,2007,32 (5): 735-741. CHEN Qiong, WU Minghua, ZHOU Yanhong, et al. Inhibitory effect of LRRC4 on the mobility and invasion of glioblastomas through the SDF-1α/CXCR4 axis［J］.Journal of Central South University. Medical Sciences, 2007, 32 (5): 735-741.

[7] Radoslaw B, Maksym, Maciej T, et al.The role of stromal-derived factor-1/CXCR7 axis in development and cancer［J］. Eur J Pharmacol, 2009, 25(12): 31-40.

[8] 武明花,王洁如,李桂源.原发性脑瘤的分子遗传学研究进展［J］.国际病理科学与临床杂志,2007,27 (3):223-226. WU Minghua, WANG Jieru, LI Guiyuan. Progression of molecular genetics in primary brain tumor［J］. International Journal of Pathology and Clinical Medicine,2007, 27 (3): 223-226.

[9] Folkman J. Tumor angiogenesis［M］//Holland JF, Bast RC, Morton DL, eds. Cancer medicine. 4th ed. Baltimore: Williarns & Wilkins, 1997:181-204.